ClinicalTrials.gov
public full text
Public Domain
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation#891995
- The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial#826505
- 2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD#912998
- 21 U.S.C. § 360bbb — Expanded access to unapproved therapies and diagnostics#577309
- Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)#1085448
Record · ID 980164
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive